Moreover, myelocytomatosis oncogene (MYC) inhibits miR-29b expression in acute promyelocytic leukemia cells and participates in the mediation of miR-29b in bone marrow differentiation (Batliner et al. 2012). This evidence concerns the gene MYC and acute promyelocytic leukemia.